Vaneck UCITS ETFs PLC - Vaneck Genomics And Healthcare Innovators UCITS ETF (LON:CURE)
London · Delayed Price · Currency is GBP · Price in USD 20.42
-0.15 (-0.74%)
At close: Jul 29, 2025, 4:30 PM BST
LON:CURE Holdings Information
LON:CURE is an equity ETF with a total of 53 individual holdings. The top holdings are Regeneron Pharmaceuticals stock at 8.38%, Vertex Pharmaceuticals at 8.14%, DexCom at 6.84%, Veeva Systems at 6.82%, and Alnylam Pharmaceuticals at 6.14%.
Total Holdings
53
Top 10 Percentage
59.89%
Asset Class
Equity
ETF Category
Theme
Assets
5.57M
PE Ratio
37.85
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals, Inc. | 8.38% |
| 2 | VRTX | Vertex Pharmaceuticals Incorporated | 8.14% |
| 3 | DXCM | DexCom, Inc. | 6.84% |
| 4 | VEEV | Veeva Systems Inc. | 6.82% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 6.14% |
| 6 | NTRA | Natera, Inc. | 4.97% |
| 7 | PODD | Insulet Corporation | 4.84% |
| 8 | ASX: PME | Pro Medicus Limited | 4.67% |
| 9 | ILMN | Illumina, Inc. | 4.63% |
| 10 | HIMS | Hims & Hers Health, Inc. | 4.46% |
| 11 | BNTX | BioNTech SE | 4.24% |
| 12 | MRNA | Moderna, Inc. | 3.77% |
| 13 | HKG: 6618 | JD Health International Inc. | 2.72% |
| 14 | QGEN | Qiagen N.V. | 2.52% |
| 15 | DOCS | Doximity, Inc. | 2.21% |
| 16 | HKG: 0241 | Alibaba Health Information Technology Limited | 2.00% |
| 17 | TYO: 2413 | M3, Inc. | 1.97% |
| 18 | EXAS | Exact Sciences Corporation | 1.91% |
| 19 | STO: SECT.B | Sectra AB (publ) | 1.82% |
| 20 | GH | Guardant Health, Inc. | 1.81% |
| 21 | CRSP | CRISPR Therapeutics AG | 1.64% |
| 22 | IONS | Ionis Pharmaceuticals, Inc. | 1.29% |
| 23 | HKG: 1548 | Genscript Biotech Corporation | 1.12% |
| 24 | IRTC | iRhythm Technologies, Inc. | 0.97% |
| 25 | RARE | Ultragenyx Pharmaceutical Inc. | 0.91% |
As of Jul 30, 2025